These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8096228)

  • 41. [Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure].
    Evdokimova AG; Radzevich AE; Tereshchenko OI; Pichugina TA; Kovalenko EV
    Kardiologiia; 2004; 44(2):15-8. PubMed ID: 15029131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy.
    Kim MH; Devlin WH; Das SK; Petrusha J; Montgomery D; Starling MR
    Circulation; 1999 Aug; 100(7):729-35. PubMed ID: 10449695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
    Van de Water A; Janssens W; Van Neuten J; Xhonneux R; De Cree J; Verhaegen H; Reneman RS; Janssen PA
    J Cardiovasc Pharmacol; 1988 May; 11(5):552-63. PubMed ID: 2455841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol.
    Eichhorn EJ; Heesch CM; Risser RC; Marcoux L; Hatfield B
    J Am Coll Cardiol; 1995 Jan; 25(1):154-62. PubMed ID: 7798494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of nebivolol in men: comparison of radionuclide angiocardiography with systolic time intervals.
    De Crée J; Franken P; Vandevivere J; Geukens H; Verhaegen H
    Angiology; 1988 Jun; 39(6):526-34. PubMed ID: 2897813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy.
    Percy RF; Bass TA; Conetta DA; Miller AB
    Clin Cardiol; 1989 Aug; 12(8):435-40. PubMed ID: 2766589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
    Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
    J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.
    Eichhorn EJ; Heesch CM; Barnett JH; Alvarez LG; Fass SM; Grayburn PA; Hatfield BA; Marcoux LG; Malloy CR
    J Am Coll Cardiol; 1994 Nov; 24(5):1310-20. PubMed ID: 7930255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of the effect of bisoprolol in dilated cardiomyopathy.
    Nyolczas N; Dekány M; Fiók J; Prëda I
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):543-50. PubMed ID: 11101203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subacute hemodynamic effects of nebivolol in man at rest and during exercise.
    De Crée J; Geukens H; Cobo C; Verhaegen H
    Angiology; 1987 Jun; 38(6):440-8. PubMed ID: 2884904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.
    Dubach P; Myers J; Bonetti P; Schertler T; Froelicher V; Wagner D; Scheidegger M; Stuber M; Luchinger R; Schwitter J; Hess O
    Am Heart J; 2002 Apr; 143(4):676-83. PubMed ID: 11923805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.